Switzerland· 50373002
Inhibace submite 1 mg, Filmtabletten
A cilazapril product, registered in Switzerland by Cheplapharm Schweiz GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Cilazapril is registered in 10 of 19 countries.
Countries holding a registration under ATC C09AA08 (cilazapril), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Cilazapril · ATC C09AA08
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cilazapril costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.22 in Spain to $0.53 in Switzerland — a ×2.4 gap.
- Switzerland: $0.53 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cilazapril · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- IT Italy$0.45
- ES Spain$0.22
The record
At a glance
- Manufacturer
- Cheplapharm Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- C09AA08
- ATC class
- Cilazapril
- Defined daily dose
- 2.5 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
69 interactions on record for cilazapril.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cilazapril · interactions on record
69 records
69 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09AA08
Cilazapril, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca3e8fd4-867b-433e-b2a6-42226850fcc7 GET /v1/drugs/ca3e8fd4-867b-433e-b2a6-42226850fcc7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about cilazapril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.